820 related articles for article (PubMed ID: 20338925)
21. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
22. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice.
Ito R; Kita M; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Iwakura Y; Okanoue T; Yoshikawa T; Kataoka K; Mazda O
Biochem Biophys Res Commun; 2008 Dec; 377(1):12-6. PubMed ID: 18796297
[TBL] [Abstract][Full Text] [Related]
23. [Effect of balsalazide on intestinal mucosal permeability of dextran sulfate sodium-induced colitis in mice].
Liu XC; Mei Q; Xu JM; Hu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Mar; 12(2):193-6. PubMed ID: 19296261
[TBL] [Abstract][Full Text] [Related]
24. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Yadav M; Huang MC; Goetzl EJ
Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
[TBL] [Abstract][Full Text] [Related]
25. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
26. PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis.
Rijcken E; Mennigen RB; Schaefer SD; Laukoetter MG; Anthoni C; Spiegel HU; Bruewer M; Senninger N; Krieglstein CF
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G446-52. PubMed ID: 17510197
[TBL] [Abstract][Full Text] [Related]
27. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.
Khalil PN; Weiler V; Nelson PJ; Khalil MN; Moosmann S; Mutschler WE; Siebeck M; Huss R
Gastroenterology; 2007 Mar; 132(3):944-54. PubMed ID: 17383423
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of phosphoinositide 3-kinase ameliorates dextran sodium sulfate-induced colitis in mice.
Peng XD; Wu XH; Chen LJ; Wang ZL; Hu XH; Song LF; He CM; Luo YF; Chen ZZ; Jin K; Lin HG; Li XL; Wang YS; Wei YQ
J Pharmacol Exp Ther; 2010 Jan; 332(1):46-56. PubMed ID: 19828878
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
[TBL] [Abstract][Full Text] [Related]
30. Adenosine kinase inhibitor GP515 improves experimental colitis in mice.
Siegmund B; Rieder F; Albrich S; Wolf K; Bidlingmaier C; Firestein GS; Boyle D; Lehr HA; Loher F; Hartmann G; Endres S; Eigler A
J Pharmacol Exp Ther; 2001 Jan; 296(1):99-105. PubMed ID: 11123368
[TBL] [Abstract][Full Text] [Related]
31. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.
Poritz LS; Garver KI; Green C; Fitzpatrick L; Ruggiero F; Koltun WA
J Surg Res; 2007 Jun; 140(1):12-9. PubMed ID: 17418867
[TBL] [Abstract][Full Text] [Related]
32. PACAP provides colonic protection against dextran sodium sulfate induced colitis.
Azuma YT; Hagi K; Shintani N; Kuwamura M; Nakajima H; Hashimoto H; Baba A; Takeuchi T
J Cell Physiol; 2008 Jul; 216(1):111-9. PubMed ID: 18205183
[TBL] [Abstract][Full Text] [Related]
33. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.
Ito R; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Kita M; Ueda Y; Iwakura Y; Kataoka K; Okanoue T; Mazda O
Clin Exp Immunol; 2006 Nov; 146(2):330-8. PubMed ID: 17034586
[TBL] [Abstract][Full Text] [Related]
34. Protection against dextran sodium sulfate-induced colitis by dehydroepiandrosterone and 7alpha-hydroxy-dehydroepiandrosterone in the rat.
Pélissier MA; Muller C; Hill M; Morfin R
Steroids; 2006 Mar; 71(3):240-8. PubMed ID: 16371229
[TBL] [Abstract][Full Text] [Related]
35. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
Kong J; Zhang Z; Musch MW; Ning G; Sun J; Hart J; Bissonnette M; Li YC
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G208-16. PubMed ID: 17962355
[TBL] [Abstract][Full Text] [Related]
36. Dextran sodium sulfate-induced colitis causes rapid bone loss in mice.
Hamdani G; Gabet Y; Rachmilewitz D; Karmeli F; Bab I; Dresner-Pollak R
Bone; 2008 Nov; 43(5):945-50. PubMed ID: 18675386
[TBL] [Abstract][Full Text] [Related]
37. The absence of functional PI3Kgamma prevents leukocyte recruitment and ameliorates DSS-induced colitis in mice.
van Dop WA; Marengo S; te Velde AA; Ciraolo E; Franco I; ten Kate FJ; Boeckxstaens GE; Hardwick JC; Hommes DW; Hirsch E; van den Brink GR
Immunol Lett; 2010 Jun; 131(1):33-9. PubMed ID: 20347874
[TBL] [Abstract][Full Text] [Related]
38. Suppression of experimental colitis by intestinal mononuclear phagocytes.
Qualls JE; Kaplan AM; van Rooijen N; Cohen DA
J Leukoc Biol; 2006 Oct; 80(4):802-15. PubMed ID: 16888083
[TBL] [Abstract][Full Text] [Related]
39. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.
Melgar S; Karlsson L; Rehnström E; Karlsson A; Utkovic H; Jansson L; Michaëlsson E
Int Immunopharmacol; 2008 Jun; 8(6):836-44. PubMed ID: 18442787
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis.
Miceli R; Hubert M; Santiago G; Yao DL; Coleman TA; Huddleston KA; Connolly K
J Pharmacol Exp Ther; 1999 Jul; 290(1):464-71. PubMed ID: 10381813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]